Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1980-07-11
1981-08-11
Waltz, Thomas A.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
260326N, 26050116, 26050118, 564153, A61K 4904, C07C103183, C07C10350
Patent
active
042833817
ABSTRACT:
Compounds of the formula ##STR1## wherein X is alkylene, optionally substituted by hydroxy, methoxy or amino;
REFERENCES:
patent: 2776241 (1957-01-01), Priewe et al.
patent: 3178473 (1965-04-01), Holtermann et al.
patent: 3701771 (1972-10-01), Almen et al.
patent: 3953501 (1976-04-01), Klieger et al.
patent: 4021481 (1977-05-01), Almen et al.
patent: 4192859 (1980-03-01), Mackaness et al.
J. Ackerman, Chem. Abstracts 72:66642d (1970).
Klieger Erich
Mutzel Wolfgang
Speck Ulrich
Schering Aktiengesellschaft
Waltz Thomas A.
LandOfFree
Triiodinated aminoacetamido isophthalamide x-ray contrast agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triiodinated aminoacetamido isophthalamide x-ray contrast agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triiodinated aminoacetamido isophthalamide x-ray contrast agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1025757